{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:06:56Z","timestamp":1789175216621,"version":"build-2803163510"},"reference-count":47,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Liver biopsy is the reference standard for the evaluation of inflammation and fibrosis in MASH and is the primary endpoint in steatohepatitis clinical trials. An optimal liver biopsy is generally considered to be obtained with a 16\u2010gauge needle, measure at least 2\u2009cm in length and contain at least 10 complete portal tracts, although these features have not been prospectively validated as mandatory thresholds in MASH trials. Published clinical trials for MASH have not consistently reported sufficient details of liver biopsy quality (needle gauge, length, number of portal tracts) at baseline or post\u2010treatment, and biopsy quality metrics are rarely reported separately by treatment arm. Placebo response rates in clinical trials for MASH varied widely (2% to 34%) and this variation could influence the outcomes of clinical trials. Future MASH trials should report biopsy quality metrics (needle gauge, core length and portal tract count) by treatment arm in supplementary appendices of those publications, treat the 16\u2010gauge\/\u2265\u20092\u2009cm\/\u2265\u200910 portal tract criteria as preferred acquisition standards rather than required thresholds, and may consider pre\u2010specified sensitivity analyses restricted to biopsies meeting adequacy criteria, recognising that such exclusions may alter the disease spectrum and must be interpreted cautiously. Biopsy quality is a plausible contributor to variability in placebo responses and trial outcomes, but direct evidence that needle gauge, core length, or portal tract number independently affect histologic response rates in randomised MASH trials remains limited. As digital pathology\/AI tools mature and NIT\u2010based surrogate endpoints advance toward regulatory qualification, ensuring high quality histologic reference standards remains essential.<\/jats:p>","DOI":"10.1111\/liv.70808","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:13:08Z","timestamp":1784722388000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liver Biopsy in Metabolic Dysfunction\u2010Associated Steatohepatitis Clinical Trials: Potential Pitfalls and Solutions"],"prefix":"10.1111","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4234-224X","authenticated-orcid":false,"given":"Eric J.","family":"Lawitz","sequence":"first","affiliation":[{"name":"The Texas Liver Institute, University of Texas Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-1569","authenticated-orcid":false,"given":"Fred","family":"Poordad","sequence":"additional","affiliation":[{"name":"The Texas Liver Institute, University of Texas Health San Antonio  San Antonio Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary D.","family":"Goodman","sequence":"additional","affiliation":[{"name":"Center for Liver Disease  Fairfax Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004"},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2025.101898"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.036"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000670"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2023.01.017"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2013-201954"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcm.2026.102831"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00191-0"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.17.17792"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80187-1"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jum.15229"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.025"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.025"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.01.011"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2022.01.009"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.06.008"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2403308"},{"issue":"1","key":"e_1_2_17_20_1","first-page":"21","article-title":"Noninvasive Methods for Assessing Liver Fibrosis and Steatosis","volume":"20","author":"Kazi I. N.","year":"2024","journal-title":"Gastroenterology & Hepatology (New York, N.Y.)"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000843"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000845"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-08850-1"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001658"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101351"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.10.015"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2025.103145"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31750"},{"key":"e_1_2_17_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304286"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401943"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(24)00246-2"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401755"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-1774"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00272-8"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61933-4"},{"key":"e_1_2_17_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2036205"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2413258"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02539-6"},{"key":"e_1_2_17_40_1","unstructured":"FDA \u201cLetter of Intent Determination Letter to the Foundation for the National Institutes of Health Biomarkers Consortium Non\u2010Invasive Biomarkers of MetaBolic Liver DiseasE (NIMBLE) \u201d2021 https:\/\/www.fda.gov\/media\/147794\/download."},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001509"},{"key":"e_1_2_17_42_1","unstructured":"FDA \u201cNoncirrhotic Nonalcoholic Steatohepatitis With Liver Fibrosis: Developing Drugs for Treatment \u201d2018 www.fda.gov\/media\/119044\/download?attachment."},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.09.035"},{"key":"e_1_2_17_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32315"},{"key":"e_1_2_17_45_1","first-page":"S1855","article-title":"Analysis of MAESTRO\u2010NASH, Resmetirom Relative to Placebo Patients, on Primary and Secondary Liver Biopsy Endpoints Based on Aligned Biopsy Endpoints and Statistical Methods: From MASH Clinical Trials","volume":"82","author":"Loomba R.","year":"2025","journal-title":"Hepatology"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.70023"},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323"},{"key":"e_1_2_17_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001608"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.70808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/liv.70808","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.70808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:20:46Z","timestamp":1789172446000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.70808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1111\/liv.70808"],"URL":"https:\/\/doi.org\/10.1111\/liv.70808","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"2026-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70808"}}